Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$134,195,115
+$4,786,590 QoQ
Shares Held
548,990
-12.2% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2026CallValue
$244,440
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MAI Capital Management holds $463,973,037 across 18 Drug Manufacturers - General names. JNJ ranks #1 (28.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
548,990 | $134,195,115 | |
| 2 | ABBV |
AbbVie Inc.
|
577,833 | $125,672,899 | |
| 3 | LLY |
ELI LILLY & Co
|
96,089 | $88,379,779 | |
| 4 | MRK |
Merck & Co., Inc.
|
335,023 | $40,299,916 | |
| 5 | AMGN |
Amgen Inc
|
87,280 | $30,709,468 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
223,761 | $13,571,104 | |
| 7 | PFE |
Pfizer Inc
|
420,692 | $11,813,031 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
44,349 | $6,180,920 |
All Filings in JNJ
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $134,195,115 | 548,990 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $244,440 | 1,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $129,408,525 | 625,313 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $206,950 | 1,000 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $112,409,391 | 606,242 | Shares | Sole | 2025-11-10 | |
| 2025-09-30 | $185,420 | 1,000 | Call | Sole | 2025-11-10 | |
| 2025-06-30 | $152,750 | 1,000 | Call | Sole | 2025-08-12 | |
| 2025-06-30 | $85,772,027 | 561,519 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $93,623,147 | 564,539 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $165,840 | 1,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $73,971,828 | 511,491 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $144,620 | 1,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $64,507,334 | 398,046 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $70,521,907 | 482,498 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $77,088,518 | 487,316 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $71,397,577 | 455,516 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $65,614,827 | 421,283 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $70,356,758 | 425,065 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $55,486,590 | 357,978 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $67,492,488 | 382,069 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $60,394,192 | 369,700 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $60,371,506 | 340,102 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $57,807,109 | 326,170 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $53,543,712 | 312,993 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $48,671,578 | 301,372 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $48,031,594 | 291,560 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $49,801,501 | 303,021 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $42,268,490 | 268,576 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $40,273,231 | 270,508 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $38,471,727 | 273,567 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $31,569,022 | 240,746 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||